Sava raises €7.4M Seed round
21 June 2024· London, United Kingdom· health, digital_health, biosensors, wearables, b2c, software_hardware
The funding will be used to expand its team, advance automated manufacturing capabilities to reach target launch volumes and accelerate the clinical validation of its microsensor technology, and to accelerate its goal of creating a new paradigm for healthcare – preventative, personalised and painless.
Investors
LeadBalderton Capital
Also participating
Exor Ventures
About Sava
Stage
Series A
Headquarters
London, United Kingdom
Founded
2019
Team Size
51–200
Sectors
healthdigital_healthbiosensorswearablesb2csoftware_hardware